Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. The STOP-NIDDM Trial. - Chiasson,J.L.; Josse,R.G.; Gomis,R. (JAMA The Journal of the American Medical Association, 2003)